LV10862A - Jauni feniletil- un fenilpropilamini - Google Patents

Jauni feniletil- un fenilpropilamini

Info

Publication number
LV10862A
LV10862A LV950156A LV950156A LV10862A LV 10862 A LV10862 A LV 10862A LV 950156 A LV950156 A LV 950156A LV 950156 A LV950156 A LV 950156A LV 10862 A LV10862 A LV 10862A
Authority
LV
Latvia
Prior art keywords
image
pct
branched
straight
alkyl group
Prior art date
Application number
LV950156A
Other languages
English (en)
Other versions
LV10862B (en
Inventor
Stefan Bengtsson
Sven Hellberg
Nina Mohell
Lian Zhang
Gerd Hallnemo
David Jackson
Bengt Ulff
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10862A publication Critical patent/LV10862A/lv
Publication of LV10862B publication Critical patent/LV10862B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
LVP-95-156A 1993-10-07 1995-06-05 Novel phenylethyl and phenylpropylamines LV10862B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303274A SE9303274D0 (sv) 1993-10-07 1993-10-07 Novel phenylethyl and phenylproplamines
PCT/SE1994/000860 WO1995009835A1 (en) 1993-10-07 1994-09-16 Novel phenylethyl and phenylpropylamines

Publications (2)

Publication Number Publication Date
LV10862A true LV10862A (lv) 1995-10-20
LV10862B LV10862B (en) 1996-08-20

Family

ID=20391336

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-156A LV10862B (en) 1993-10-07 1995-06-05 Novel phenylethyl and phenylpropylamines

Country Status (31)

Country Link
US (1) US5693630A (lv)
EP (1) EP0672032B1 (lv)
JP (1) JPH08504835A (lv)
KR (1) KR950704236A (lv)
CN (1) CN1048718C (lv)
AT (1) ATE161823T1 (lv)
AU (1) AU680303B2 (lv)
BR (1) BR9405632A (lv)
CA (1) CA2150005A1 (lv)
CZ (1) CZ148595A3 (lv)
DE (1) DE69407751T2 (lv)
DK (1) DK0672032T3 (lv)
EE (1) EE03214B1 (lv)
ES (1) ES2111959T3 (lv)
FI (1) FI952772A0 (lv)
GR (1) GR3026484T3 (lv)
HU (1) HUT73774A (lv)
IL (1) IL111133A (lv)
IS (1) IS4204A (lv)
LT (1) LT3920B (lv)
LV (1) LV10862B (lv)
NO (1) NO305947B1 (lv)
NZ (1) NZ274273A (lv)
PL (1) PL179011B1 (lv)
RU (1) RU2133735C1 (lv)
SE (1) SE9303274D0 (lv)
SI (1) SI9420007A (lv)
SK (1) SK67295A3 (lv)
TW (1) TW338036B (lv)
WO (1) WO1995009835A1 (lv)
ZA (1) ZA947209B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60114413T2 (de) 2000-05-25 2006-07-27 F. Hoffmann-La Roche Ag Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten
EP1425008B1 (en) * 2001-09-12 2006-10-04 MERCK PATENT GmbH Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7644E (fr) 1903-08-11 1907-09-17 Chappee Et Fils Soc Nouveau système d'assainissement des villes
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
FR7644M (lv) * 1968-06-24 1970-02-02
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
DE2345423A1 (de) * 1973-09-08 1975-03-20 Thomae Gmbh Dr K Neue substituierte phenylaethylaminderivate, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
US4021558A (en) * 1973-09-08 1977-05-03 Boehringer Ingelheim Gmbh 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents
JPS5414956A (en) * 1977-07-04 1979-02-03 Sumitomo Chem Co Ltd Novel 3-amino-4-homoisotwistan derivative
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
FR2608157B1 (fr) * 1986-12-11 1989-09-08 Roussel Uclaf Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires
EP0274674B1 (fr) 1986-12-12 1991-05-08 Sediver, Societe Europeenne D'isolateurs En Verre Et Composite Procédé de fabrication d'un parafoudre et parafoudre obtenu par ce procédé

Also Published As

Publication number Publication date
IL111133A (en) 1998-12-27
NO952232D0 (no) 1995-06-06
ATE161823T1 (de) 1998-01-15
AU7825694A (en) 1995-05-01
BR9405632A (pt) 1999-05-25
NO305947B1 (no) 1999-08-23
EP0672032A1 (en) 1995-09-20
NZ274273A (en) 1996-10-28
PL309189A1 (en) 1995-09-18
CA2150005A1 (en) 1995-04-13
IL111133A0 (en) 1994-12-29
US5693630A (en) 1997-12-02
NO952232L (no) 1995-07-18
CN1048718C (zh) 2000-01-26
DE69407751T2 (de) 1998-04-16
HU9501643D0 (en) 1995-08-28
ZA947209B (en) 1995-07-07
LV10862B (en) 1996-08-20
CN1115575A (zh) 1996-01-24
AU680303B2 (en) 1997-07-24
TW338036B (en) 1998-08-11
DE69407751D1 (de) 1998-02-12
IS4204A (is) 1995-04-08
FI952772A (fi) 1995-06-06
LT95059A (en) 1995-10-25
ES2111959T3 (es) 1998-03-16
SK67295A3 (en) 1996-09-04
SI9420007A (en) 1996-04-30
CZ148595A3 (en) 1996-01-17
SE9303274D0 (sv) 1993-10-07
HUT73774A (en) 1996-09-30
PL179011B1 (pl) 2000-07-31
FI952772A0 (fi) 1995-06-06
EP0672032B1 (en) 1998-01-07
EE03214B1 (et) 1999-08-16
JPH08504835A (ja) 1996-05-28
WO1995009835A1 (en) 1995-04-13
KR950704236A (ko) 1995-11-17
RU2133735C1 (ru) 1999-07-27
RU95112451A (ru) 1997-04-20
GR3026484T3 (en) 1998-06-30
DK0672032T3 (da) 1998-05-04
LT3920B (en) 1996-04-25

Similar Documents

Publication Publication Date Title
ATE186727T1 (de) Substituierte 3-arylidinene-7-azaoxindol verbindungen und verfahren zu ihrer herstellung
DE69615558D1 (de) Zns-aktive semicarbazone und diese enthaltende pharmazeutische zubereitungen
RU96117041A (ru) Применение производных 2-гидрокси-5-фенилазобензойной кислоты в качестве химиопрофилактических и химиотерапевтических агентов при раке ободочной кишки
DK0672032T3 (da) Hidtil ukendte phenylethyl- og phenylpropylaminer
GR3023934T3 (en) New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them
MY102219A (en) Leukotriene antagonists
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
ES2131549T3 (es) Derivados macrolidas de 16 eslabones y su procedimiento de preparacion.
DE69320367D1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
ITMI910658A1 (it) N-(4, 5-diidrossi-e 4, 5, 8-triidrossi-9, 10-diidro-9, 10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
ZA979328B (en) Process for the preparation of n-[2-(dimethylamino)ethyl[acridine-4-carboxamide
UA34451C2 (uk) 2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи
ATE56705T1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE83484T1 (de) 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen.
HUP0303691A2 (hu) Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására
TH17403EX (th) เฟนิลเอธิลามีนและเฟนิลโพรพิลามีนชนิดใหม่
TH17403A (th) เฟนิลเอธิลามีนและเฟนิลโพรพิลามีนชนิดใหม่
ATE167873T1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
HU9202462D0 (en) Method for producing new 2-imidazolyl derivatives of substituted bicyclic compounds and pharmaceutical preparatives containing them as active agent